Big Pharma

The term "Big Pharma" refers to the world's largest pharmaceutical corporations. While not a single organization, it's a collective descriptor for major players in the drug development and healthcare industry. Currently, these entities are navigating increased geopolitical complexities, particularly in cross-border biotech deals. Recent news highlights that the United States is intensifying efforts to restrict investment and technology transfers, especially concerning China. This heightened scrutiny, according to industry analysts, is likely to lead to a modest slowdown in such international collaborations. The underlying context involves a growing trend of institutional distrust and a rise in alternative wellness movements, though this specific article focuses on the regulatory and geopolitical challenges impacting the global pharmaceutical landscape and its investment strategies.